SCHEMBL1164166

SCHEMBL1164166

CC(=O)NCCCBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8119796 0.92
SCHEMBL22635006 0.90 KDM4E (0.76)
SCHEMBL1681641 0.83
SCHEMBL1900471 0.83 KDM4E (0.82)
SCHEMBL860791 0.83 KDM4E (0.94)
SCHEMBL14740196 0.80 KDM4E (1.00)
SCHEMBL14739904 0.80 KDM4E (1.00)
SCHEMBL1900654 0.80 KDM4E (1.00)
SCHEMBL14740132 0.80 KDM4E (1.00)
SCHEMBL14739632 0.80 KDM4E (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115010645-A Preparation method of melatonin 广西师范大学 2022-09-06 CN claimed
EP-4463457-B1 PYRROLO[1,2-B]-2-PYRIDAZINONE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS SUVEN LIFE SCIENCES LTD (IN) 2026-02-04 EP disclosed
US-20250154191-A1 OLIGONUCLEOTIDE PRODUCTION METHOD LIID PHARMACEUTICALS, INC. (JP) 2025-05-15 US disclosed
US-12275746-B2 Pyrrolo[1,2-b]-2-pyridazinone compounds as 5-HT4 receptor agonists SUVEN LIFE SCIENCES LIMITED (IN) 2025-04-15 US disclosed
US-20250019386-A1 PYRROLO[1,2-b]-2-PYRIDAZINONE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS SUVEN LIFE SCIENCES LIMITED (IN) 2025-01-16 US disclosed
EP-4450512-A1 OLIGONUCLEOTIDE PRODUCTION METHOD LIID Pharmaceuticals, Inc. (JP) 2024-10-23 EP disclosed
US-11725000-B2 Apoptosis inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2023-08-15 US disclosed
WO-2023113038-A1 OLIGONUCLEOTIDE PRODUCTION METHOD リードファーマ株式会社 2023-06-22 WO disclosed
CN-111727186-B Biheterocyclic substituted pyridine-2 (1H) -ketone derivative, preparation method and medical application thereof 上海海雁医药科技有限公司 2022-11-08 CN disclosed
CN-110023292-B Apoptosis inhibitors 北京生命科学研究所 2022-10-04 CN disclosed
US-20080255085-A1 Novel Imidazo [4,5-b] Pyridine Derivatives as Inhibitors of Glycogen Synthase Kinase 3 for Use in the Treatment of Dementia and Neurodegenerative Disorders ASTRAZENECA AB (SE) 2008-10-16 US disclosed
US-20080255085-A1 Novel Imidazo [4,5-b] Pyridine Derivatives as Inhibitors of Glycogen Synthase Kinase 3 for Use in the Treatment of Dementia and Neurodegenerative Disorders ASTRAZENECA AB (SE) 2008-10-16 US disclosed
EP-1947105-A1 Method for single-step attachment of a label to target molecules Mirus Bio Corporation (US) 2008-07-23 EP disclosed
EP-1937680-A2 NOVEL IMIDAZO [4,5 -B] PYRIDINE DERIVATIVES AS INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 FOR USE IN THE TREATMENT OF DEMENTIA AND NEURODEGENERATIVE DISORDERS AstraZeneca AB (SE) 2008-07-02 EP disclosed
WO-2007040438-A2 NOVEL IMIDAZO [4,5 -B] PYRIDINE DERIVATIVES AS INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 FOR USE IN THE TREATMENT OF DEMENTIA AND NEURODEGENERATIVE DISORDERS ASTRAZENECA AB (SE) 2007-04-12 WO disclosed
EP-1082110-B1 USE OF COMPOUNDS FOR THE ELEVATION OF PYRUVATE DEHYDROGENASE ACTIVITY ASTRAZENECA AB (SE) 2004-03-24 EP disclosed
CN-1303281-A Application of compound in enhancing activity of pyruvate dehydrogenase ASTRA ZENECA LTD (SE) 2001-07-11 CN disclosed
EP-0024510-B1 PHENOXYPROPYL AMINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM TEIKOKU HORMONE MFG. CO., LTD. (JP) 1983-10-19 EP disclosed
US-4293557-A AMIDES TEIKOKU HORMONE MFG. CO., LTD. (JP) 1981-10-06 US disclosed
EP-0024510-A1 Phenoxypropyl amine derivatives, process for their preparation, and pharmaceutical compositions containing them TEIKOKU HORMONE MFG. CO., LTD. (JP) 1981-03-11 EP disclosed